rs3802149

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003114.5(SPAG1):​c.939+13T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.2 in 1,548,334 control chromosomes in the GnomAD database, including 32,478 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.17 ( 2456 hom., cov: 32)
Exomes 𝑓: 0.20 ( 30022 hom. )

Consequence

SPAG1
NM_003114.5 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.127

Publications

8 publications found
Variant links:
Genes affected
SPAG1 (HGNC:11212): (sperm associated antigen 1) The correlation of anti-sperm antibodies with cases of unexplained infertility implicates a role for these antibodies in blocking fertilization. Improved diagnosis and treatment of immunologic infertility, as well as identification of proteins for targeted contraception, are dependent on the identification and characterization of relevant sperm antigens. The protein expressed by this gene is recognized by anti-sperm agglutinating antibodies from an infertile woman. Furthermore, immunization of female rats with the recombinant human protein reduced fertility. This protein localizes to the plasma membrane of germ cells in the testis and to the post-acrosomal plasma membrane of mature spermatozoa. Recombinant polypeptide binds GTP and exhibits GTPase activity. Thus, this protein may regulate GTP signal transduction pathways involved in spermatogenesis and fertilization. Two transcript variants of this gene encode the same protein. [provided by RefSeq, Jul 2008]
SPAG1 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 28
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, PanelApp Australia, G2P
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BP6
Variant 8-100191509-T-C is Benign according to our data. Variant chr8-100191509-T-C is described in ClinVar as Benign. ClinVar VariationId is 262804.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.217 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SPAG1NM_003114.5 linkc.939+13T>C intron_variant Intron 9 of 18 ENST00000388798.7 NP_003105.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SPAG1ENST00000388798.7 linkc.939+13T>C intron_variant Intron 9 of 18 1 NM_003114.5 ENSP00000373450.3

Frequencies

GnomAD3 genomes
AF:
0.168
AC:
25513
AN:
152082
Hom.:
2459
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0747
Gnomad AMI
AF:
0.145
Gnomad AMR
AF:
0.180
Gnomad ASJ
AF:
0.228
Gnomad EAS
AF:
0.0722
Gnomad SAS
AF:
0.229
Gnomad FIN
AF:
0.247
Gnomad MID
AF:
0.228
Gnomad NFE
AF:
0.209
Gnomad OTH
AF:
0.187
GnomAD2 exomes
AF:
0.199
AC:
48737
AN:
245260
AF XY:
0.204
show subpopulations
Gnomad AFR exome
AF:
0.0716
Gnomad AMR exome
AF:
0.217
Gnomad ASJ exome
AF:
0.225
Gnomad EAS exome
AF:
0.0562
Gnomad FIN exome
AF:
0.249
Gnomad NFE exome
AF:
0.208
Gnomad OTH exome
AF:
0.218
GnomAD4 exome
AF:
0.203
AC:
283893
AN:
1396134
Hom.:
30022
Cov.:
22
AF XY:
0.205
AC XY:
142912
AN XY:
698032
show subpopulations
African (AFR)
AF:
0.0666
AC:
2125
AN:
31910
American (AMR)
AF:
0.211
AC:
9189
AN:
43606
Ashkenazi Jewish (ASJ)
AF:
0.227
AC:
5812
AN:
25642
East Asian (EAS)
AF:
0.0795
AC:
3131
AN:
39360
South Asian (SAS)
AF:
0.247
AC:
20739
AN:
83824
European-Finnish (FIN)
AF:
0.256
AC:
13605
AN:
53210
Middle Eastern (MID)
AF:
0.243
AC:
1371
AN:
5638
European-Non Finnish (NFE)
AF:
0.205
AC:
216283
AN:
1054668
Other (OTH)
AF:
0.200
AC:
11638
AN:
58276
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
10796
21592
32388
43184
53980
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
7284
14568
21852
29136
36420
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.168
AC:
25508
AN:
152200
Hom.:
2456
Cov.:
32
AF XY:
0.169
AC XY:
12589
AN XY:
74404
show subpopulations
African (AFR)
AF:
0.0747
AC:
3103
AN:
41552
American (AMR)
AF:
0.180
AC:
2753
AN:
15282
Ashkenazi Jewish (ASJ)
AF:
0.228
AC:
791
AN:
3470
East Asian (EAS)
AF:
0.0722
AC:
374
AN:
5182
South Asian (SAS)
AF:
0.228
AC:
1102
AN:
4830
European-Finnish (FIN)
AF:
0.247
AC:
2610
AN:
10564
Middle Eastern (MID)
AF:
0.221
AC:
65
AN:
294
European-Non Finnish (NFE)
AF:
0.209
AC:
14189
AN:
68006
Other (OTH)
AF:
0.185
AC:
389
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.507
Heterozygous variant carriers
0
1107
2213
3320
4426
5533
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
292
584
876
1168
1460
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.201
Hom.:
4408
Bravo
AF:
0.157
Asia WGS
AF:
0.150
AC:
522
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Nov 27, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Primary ciliary dyskinesia 28 Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
7.0
DANN
Benign
0.65
PhyloP100
0.13
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs3802149; hg19: chr8-101203737; API